Systematic review / meta-analysis / 2020
Saffron improved depressive symptoms better than placebo and was as effective as synthetic antidepressants in mild to moderate depression.
A systematic review and meta-analysis of 12 studies evaluated the efficacy and safety of saffron (Crocus sativus L.) compared with placebo or antidepressants for mild to moderate depression. Overall results showed saffron possessed better efficacy in improving depressive symptoms compared with placebo and was as effective as synthetic antidepressants. No significant differences were detected in adverse effect incidence between saffron and placebo or between saffron and antidepressants. Authors noted that multicenter trials with larger sample sizes, longer treatment durations, and diverse ethnic groups are needed to verify the results.
- Study type
- Systematic review and meta-analysis of clinical trials
- Who was studied
- Individuals with mild to moderate depression across 12 included studies
- What was measured
- Depressive symptom scores, response rate, remission rate, and adverse effects
THE PAPER
Safety and Efficacy of Saffron (Crocus sativus L.) for Treating Mild to Moderate Depression: A Systematic Review and Meta-analysis.
Dai L, Chen L, Wang W. J Nerv Ment Dis, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.